在T细胞中的雄激素受体活性限制了检查点阻断的有效性
Xiangnan Guan1,2,3, Fanny Polesso4, Chaojie Wang4,5
1Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA.
Nature
|March 24, 2022
概括
安德روج因受体 (AR) 阻塞增强了CD8T细胞的功能,改善了前列腺癌的免疫治疗反应. 这种方法可以防止T细胞耗尽,并通过增强IFNγ表达来增加抗瘤免疫力.
科学领域:
- 癌症学
- 免疫学
- 分子生物学
背景情况:
- 免疫检查点封锁彻底改变了癌症治疗,
- 抗瘤T细胞的治疗是前列腺癌的标准治疗.
研究的目的:
- 调查雄激素受体 (AR) 阻断是否可以使前列腺瘤对免疫治疗敏感.
- 阐明AR信号影响T细胞功能和免疫治疗反应的机制.
主要方法:
- 抑制来自瘤宿主的CD8T细胞中的AR活性.
- 评估T细胞耗尽标记和对PD-1封锁的反应.
- 对干扰因子 (IFNγ) 表达和对IFng基因的AR结合的分析.
主要成果:
- 抗逆转基因阻塞防止了CD8T细胞的消耗,并增强了PD-1向治疗的反应.
- 抑制CD8T细胞的AR活性导致IFNγ的产生增加.
- 发现AR直接与Ifng基因结合,其驱逐增加了CD8 T细胞细胞因子的产生.
结论:
- 抑制IFNγ表达,这是前列腺癌中免疫疗法耐药性的新机制.
- 针对T细胞的AR可以提高免疫疗法的有效性,为治疗晚期前列腺癌提供新的策略.
相关概念视频
T Cell Activation and Clonal Selection
6.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
6.7K
Tumor Immunotherapy
699
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
699
Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
Receptor Downregulation in MVBs
2.2K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.2K
Inhibition of Cdk Activity
5.0K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
T Cell Types and Functions
1.5K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.5K


